| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $73.0M+202.1% | $24.2M+167.0% | $9.1M+105.3% | $4.4M+59.1% | $2.8M |
| Cost of revenue | $64.7M+52.4% | $42.5M+79.1% | $23.7M+135.8% | $10.1M+41.7% | $7.1M |
| Gross profit (loss) | $8.3M+145.1% | -$18.3M-24.9% | -$14.7M-159.6% | -$5.7M-30.6% | -$4.3M |
| Research and development | $9.4M+28.4% | $7.3M+99.7% | $3.7M+81.4% | $2.0M+39.8% | $1.4M |
| Selling, general and administrative | $23.0M+22.6% | $18.7M-8.0% | $20.4M+96.5% | $10.4M+113.9% | $4.8M |
| Impairment and other | $22.5M+1109.7% | $1.9M | — | — | — |
| Total operating expenses | $54.9M+96.6% | $27.9M+16.2% | $24.0M+94.0% | $12.4M+96.8% | $6.3M |
| Loss from operations | -$46.6M-0.8% | -$46.3M-19.5% | -$38.7M-114.6% | -$18.0M-69.8% | -$10.6M |
| Interest income and other, net | $2.6M+64.8% | $1.6M-36.7% | $2.5M+254.6% | $709K+4531.3% | -$16K |
| Total other income, net | $2.6M+64.8% | $1.6M-17.7% | $1.9M+172.6% | $709K-2.5% | $727K |
| Net loss | -$44.0M+1.4% | -$44.7M-21.5% | -$36.8M-112.2% | -$17.3M-75.1% | -$9.9M |
| Weighted-average common shares outstanding, basic (in shares) | 124.64B+22.3% | 101.87B+118086.3% | 86.2M-99.9% | 71.34B+8.5% | 65.76B |
| Weighted-average common shares outstanding, diluted (in shares) | 124.64B+22.3% | 101.87B+118086.3% | 86.2M-99.9% | 71.34B+8.5% | 65.76B |
| Net loss per share of common stock, basic (in dollars per share) | -$350.00+22.2% | -$450.00-104551.2% | -$0.43+99.8% | -$240.00-60.0% | -$150.00 |
| Net loss per share of common stock, diluted (in dollars per share) | -$350.00-77677.8% | -$0.45-4.7% | -$0.43+99.8% | -$240.00-60.0% | -$150.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.